Gadopiclenol:

The highest relaxivity of all GBCAs today1

 

Gadopiclenol demonstrates 2- to 3-fold higher R1 relaxivity in serum than currently approved GBCAs 
at all field strengths of MRI scanners.1-5

table relaxivity serum corr

See the Difference. Make a Difference.

*For details on indications please refer to locally approved Summary of Product Characteristics.

All images shown are representative images from referenced studies. Individual results may vary.

The individuals who appear are for illustrative purposes. All persons depicted are models and not real patients or healthcare professionals.

The vials that appear are for illustrative purposes only.

References

 

1. Robic C, Port M, Rousseaux O, et al. Physicochemical and Pharmacokinetic Profiles of Gadopiclenol: A New Macrocyclic Gadolinium Chelate with High T1 Relaxivity. Invest Radiol 2019; 54: 475-484.

2 VUEWAY® (gadopiclenol) SmPC, EMA, October 2023

3 GADOVIST® (gadobutrol) SmPC, 07/2022.

4 ProHance® (Gadoteridol) SmPC UK, 11/2022.

5  DOTAREM® (gadoterate meglumine) SmPC 07/2022.